Molecule Information
General Information of the Molecule (ID: Mol05308)
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Neuroblastoma [ICD-11: 2A00.02] | [1] | |||
| Resistant Disease | Neuroblastoma [ICD-11: 2A00.02] | |||
| Resistant Drug | Doxorubicin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | FBXW7/c-Myc signalling pathway | Regulation | N.A. | |
| In Vitro Model | SH-SY5Y cells | Abdomen | Homo sapiens (Human) | CVCL_0019 |
| Kelly cells | Adrenal | Homo sapiens (Human) | CVCL_2092 | |
| Experiment for Molecule Alteration |
RT-qPCR | |||
| Experiment for Drug Resistance |
Luminescence-based cell viability analysis | |||
| Mechanism Description | However, it certainly is of interest to highlight the possible involvement of such miRNAs in affecting the most common means of chemoresistance-inducing cellular pathways within such cell lines. A typical example would be the effect of such miRNAs on the ABC transporter system and its member genes that regulate drug efflux properties of the cell. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Neuroblastoma [ICD-11: 2A00.02] | [1] | |||
| Resistant Disease | Neuroblastoma [ICD-11: 2A00.02] | |||
| Resistant Drug | Etoposide | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | SH-SY5Y cells | Abdomen | Homo sapiens (Human) | CVCL_0019 |
| Kelly cells | Adrenal | Homo sapiens (Human) | CVCL_2092 | |
| Experiment for Molecule Alteration |
RT-qPCR | |||
| Experiment for Drug Resistance |
Luminescence-based cell viability analysis | |||
| Mechanism Description | However, it certainly is of interest to highlight the possible involvement of such miRNAs in affecting the most common means of chemoresistance-inducing cellular pathways within such cell lines. A typical example would be the effect of such miRNAs on the ABC transporter system and its member genes that regulate drug efflux properties of the cell. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
